CHAPTER 1. Industry Overview of Hospital Acquired Infection Control
1.1. Definition and Scope
1.1.1. Definition of Hospital Acquired Infection Control
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Hospital Acquired Infection Control Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Hospital Acquired Infection Control Market By Type
1.2.3. Hospital Acquired Infection Control Market By End Use
1.2.4. Hospital Acquired Infection Control Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Hospital Acquired Infection Control Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Hospital Acquired Infection Control Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2020
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2020
4.2. R&D Status and Application Source of Hospital Acquired Infection Control Major Manufacturers in 2020
CHAPTER 5. Hospital Acquired Infection Control Market By Type
5.1. Introduction
5.2. Hospital Acquired Infection Control Revenue By Type
5.2.1. Hospital Acquired Infection Control Revenue (US$ Mn) and Forecast, By Type, 2017-2028
5.2.2. Equipment
5.2.2.1. Equipment Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3. Services
5.2.3.1. Services Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.4. Consumables
5.2.4.1. Consumables Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 6. Hospital Acquired Infection Control Market Revenue By End Use
6.1. Introduction
6.2. Hospital Acquired Infection Control Revenue (US$ Mn) By End Use
6.2.1. Hospital Acquired Infection Control Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
6.2.2. Hospitals and Intensive Care Units (ICUs)
6.2.2.1. Hospitals and Intensive Care Units (ICUs) Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.3. Ambulatory Surgical and Diagnostic Centers
6.2.3.1. Ambulatory Surgical and Diagnostic Centers Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.4. Others
6.2.4.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 7. North America Hospital Acquired Infection Control Market By Country
7.1. North America Hospital Acquired Infection Control Overview
7.2. U.S.
7.2.1. U.S. Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
7.2.2. U.S. Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
7.3. Canada
7.3.1. Canada Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
7.3.2. Canada Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
7.4. North America PEST Analysis
CHAPTER 8. Europe Hospital Acquired Infection Control Market By Country
8.1. Europe Hospital Acquired Infection Control Market Overview
8.2. U.K.
8.2.1. U.K. Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
8.2.2. U.K. Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
8.3. Germany
8.3.1. Germany Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
8.3.2. Germany Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
8.4. France
8.4.1. France Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
8.4.2. France Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
8.5. Spain
8.5.1. Spain Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
8.5.2. Spain Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
8.6. Rest of Europe
8.6.1. Rest of Europe Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
8.6.2. Rest of Europe Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Hospital Acquired Infection Control Market By Country
9.1. Asia Pacific Hospital Acquired Infection Control Market Overview
9.2. China
9.2.1. China Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
9.2.2. China Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.3. Japan
9.3.1. Japan Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
9.3.2. Japan Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.4. India
9.4.1. India Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
9.4.2. India Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.5. Australia
9.5.1. Australia Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
9.5.2. Australia Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.6. South Korea
9.6.1. South Korea Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
9.6.2. South Korea Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
9.7.2. Rest of Asia-Pacific Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Hospital Acquired Infection Control Market By Country
10.1. Latin America Hospital Acquired Infection Control Market Overview
10.2. Brazil
10.2.1. Brazil Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
10.2.2. Brazil Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
10.3. Mexico
10.3.1. Mexico Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
10.3.2. Mexico Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
10.4. Rest of Latin America
10.4.1. Rest of Latin America Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
CHAPTER 11. Middle East & Africa Hospital Acquired Infection Control Market By Country
11.1. Middle East & Africa Hospital Acquired Infection Control Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
11.2.2. Saudi Arabia Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
11.3. UAE
11.3.1. UAE Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
11.3.2. UAE Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By Type, 2017-2028
11.4.2. Rest of Middle East & Africa Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
CHAPTER 12. PLAYER ANALYSIS OF HOSPITAL ACQUIRED INFECTION CONTROL
12.1. Hospital Acquired Infection Control Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Hospital Acquired Infection Control Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. COMPANY PROFILE
13.1. Olympus Corporation
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2020
13.1.3.2. Olympus Corporation 2020 Hospital Acquired Infection Control Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. BD
13.3. Getinge AB
13.4. Xenex Disinfection Services Inc.
13.5. 3M
13.6. STERIS
13.7. ASP
13.8. Ecolab
13.9. Belimed AG
13.10. KCWW
13.11. Others
The global hospital acquired infection control market in 2028 is expected to be above US$ 7.8 Bn.
The CAGR of the global hospital acquired infection control market from 2021-2028 is above 5.1%.
Rise in number of inpatients in hospitals related to various diseases and increasing awareness among consumers related to HAI are major factors expected to drive the growth of global hospital acquired infection control market.
In type the consumables segment is growing at faster pace.
In the global market the Asia Pacific region is expected to grow faster.
Some of the players considered in the report scope are Olympus Corporation, BD, Getinge AB, Xenex Disinfection Services Inc., and 3M.
The North America is expected to account for major revenue share in the global market.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date